517 related articles for article (PubMed ID: 33427197)
21. Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.
Boström M; Larsson E
Nat Commun; 2022 Nov; 13(1):7023. PubMed ID: 36396655
[TBL] [Abstract][Full Text] [Related]
22. Passenger mutations accurately classify human tumors.
Salvadores M; Mas-Ponte D; Supek F
PLoS Comput Biol; 2019 Apr; 15(4):e1006953. PubMed ID: 30986244
[TBL] [Abstract][Full Text] [Related]
23. Passenger Hotspot Mutations in Cancer.
Hess JM; Bernards A; Kim J; Miller M; Taylor-Weiner A; Haradhvala NJ; Lawrence MS; Getz G
Cancer Cell; 2019 Sep; 36(3):288-301.e14. PubMed ID: 31526759
[TBL] [Abstract][Full Text] [Related]
24. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
Anoosha P; Sakthivel R; Michael Gromiha M
Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
[TBL] [Abstract][Full Text] [Related]
25. Impact of deleterious passenger mutations on cancer progression.
McFarland CD; Korolev KS; Kryukov GV; Sunyaev SR; Mirny LA
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2910-5. PubMed ID: 23388632
[TBL] [Abstract][Full Text] [Related]
26. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
27. Somatic selection distinguishes oncogenes and tumor suppressor genes.
Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
[TBL] [Abstract][Full Text] [Related]
28. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR; Pan TC; Pant DK; Shih NNC; Chen Y; Belka GK; Feldman M; DeMichele A; Chodosh LA
Genome Med; 2024 Feb; 16(1):26. PubMed ID: 38321573
[TBL] [Abstract][Full Text] [Related]
29. Biological background of the genomic variations of cf-DNA in healthy individuals.
Liu J; Chen X; Wang J; Zhou S; Wang CL; Ye MZ; Wang XY; Song Y; Wang YQ; Zhang LT; Wu RH; Yang HM; Zhu SD; Zhou MZ; Zhang XC; Zhu HM; Qian ZY
Ann Oncol; 2019 Mar; 30(3):464-470. PubMed ID: 30475948
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer.
Zhang L; Komurov K; Wright WE; Shay JW
Int J Cancer; 2013 Feb; 132(3):732-7. PubMed ID: 22753261
[TBL] [Abstract][Full Text] [Related]
31. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Merid SK; Goranskaya D; Alexeyenko A
BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of driver and passenger mutations during tumor progression.
Bozic I; Antal T; Ohtsuki H; Carter H; Kim D; Chen S; Karchin R; Kinzler KW; Vogelstein B; Nowak MA
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18545-50. PubMed ID: 20876136
[TBL] [Abstract][Full Text] [Related]
34. Prediction of cancer driver mutations in protein kinases.
Torkamani A; Schork NJ
Cancer Res; 2008 Mar; 68(6):1675-82. PubMed ID: 18339846
[TBL] [Abstract][Full Text] [Related]
35. Statistical method on nonrandom clustering with application to somatic mutations in cancer.
Ye J; Pavlicek A; Lunney EA; Rejto PA; Teng CH
BMC Bioinformatics; 2010 Jan; 11():11. PubMed ID: 20053295
[TBL] [Abstract][Full Text] [Related]
36. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
37. Driver gene mutations based clustering of tumors: methods and applications.
Zhang W; Flemington EK; Zhang K
Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
[TBL] [Abstract][Full Text] [Related]
38. Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis.
Babenko VN; Basu MK; Kondrashov FA; Rogozin IB; Koonin EV
BMC Cancer; 2006 Feb; 6():36. PubMed ID: 16469093
[TBL] [Abstract][Full Text] [Related]
39. What can we learn about acid-base transporters in cancer from studying somatic mutations in their genes?
White B; Swietach P
Pflugers Arch; 2024 Apr; 476(4):673-688. PubMed ID: 37999800
[TBL] [Abstract][Full Text] [Related]
40. Bayesian inference of negative and positive selection in human cancers.
Weghorn D; Sunyaev S
Nat Genet; 2017 Dec; 49(12):1785-1788. PubMed ID: 29106416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
